CLRB - Cellectar Biosciences, Inc.
2.75
-0.010 -0.364%
Share volume: 114,458
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 10-29-2024 | 10-29-2024 | 11-18-2024 | 03-13-2025 | 05-13-2025 | 08-14-2025 | 11-13-2025 | 03-04-2026 | |
| Cash flow financing | 43.849 M | 1.000 | 17.561 M | 0.000 | 0.000 | 2.251 M | 5.788 M | 4.992 M | |
| Other financing cash flows | 43.849 M | 1.000 | 17.561 M | 0.000 | 0.000 | 2.251 M | -2.251 M | 7.243 M | |
| Cash flow | 30.466 M | -14.162 M | 0.000 | 0.000 | -9.383 M | 0.000 | 0.000 | 641.744 K | |
| Net income | -26.642 M | -919.371 K | -14.665 M | -2.355 M | -6.604 M | -5.448 M | -4.444 M | -5.295 M | |
| Depreciation | 88.490 K | 66.021 K | 68.571 K | 68.571 K | 56.295 K | 55.564 K | 52.277 K | 49.461 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -21.633 K | -21.276 K | 0.000 | -61.286 K | 0.000 | 0.000 | 0.000 | -5.880 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 21.633 K | 21.276 K | 0.000 | 61.286 K | 0.000 | 0.000 | 0.000 | 5.880 K | |
| Cash Change | 30.466 M | -14.162 M | 8.394 M | -10.975 M | -9.383 M | -2.864 M | 1.513 M | 641.744 K |